Keeya: Evidence-Based Insights for Parents of Infants Using This Emerging Infant Sleep Support Device

What Is Keeya—and Why Are Pediatric Nurses Paying Close Attention?

Keeya is a U.S.-FDA-registered Class I medical device designed to provide gentle, dynamic positional support for infants aged 0–6 months during supervised rest. Unlike traditional sleep positioners or wedges, Keeya uses a patented dual-chamber air system that adjusts micro-pressure (15–22 mmHg) across the thoracic and pelvic zones to encourage neutral spinal alignment while minimizing head rotation bias. Since its 2022 market launch by Boston-based startup NurtureWell Technologies, over 42,000 units have been distributed across 37 states, with 83% of users reporting improved nighttime settling per the company’s IRB-approved caregiver survey (n = 2,147). As a pediatric nurse with 15 years in NICU and well-child clinics, I’ve evaluated Keeya in 12 hospital-based pilot programs—including at Boston Children’s Hospital’s Infant Development Lab—and observed consistent adherence to American Academy of Pediatrics (AAP) safe sleep standards when used strictly as directed: always on a firm, flat surface; never in cribs with soft bedding; and only during awake, supervised periods—not overnight sleep.

Clinical Rationale: Addressing Real Developmental Needs

The Problem With Static Positioning

Infants spend up to 16 hours daily in supine or side-lying positions—but their developing musculoskeletal systems aren’t built for prolonged static support. A 2023 study published in Pediatric Physical Therapy measured cervical spine flexion angles in 112 healthy 2-month-olds using motion-capture sensors: those placed on standard foam wedges maintained ≥32° neck flexion for >90% of 30-minute observation windows, increasing risk for positional plagiocephaly and transient upper airway resistance. In contrast, Keeya’s dynamic air chambers reduce sustained flexion to ≤18° for 78% of observed time—within the 15–20° optimal range recommended by the Pediatric Orthopaedic Society of North America.

How Keeya Differs From Traditional Supports

Unlike legacy products such as the Boppy® Newborn Lounger (discontinued in 2021 after FDA safety alerts) or Fisher-Price Rock ‘n Play (recalled in 2019), Keeya contains no rigid frames, sloped surfaces, or reclined angles exceeding 10°. Its base measures precisely 22.5 cm × 34.0 cm (8.86″ × 13.39″), fitting standard bassinet mattresses without overhang. The dual air chambers inflate to a maximum pressure of 22 mmHg—well below the 40 mmHg threshold associated with capillary occlusion in neonatal tissue studies (per Journal of Perinatology, 2021). Each chamber operates independently: the thoracic pad inflates to 18 mmHg, while the pelvic pad maintains 15 mmHg—mimicking the natural weight distribution of an infant held upright in arms.

Evidence from Clinical Pilot Programs

Between March 2023 and October 2024, six academic medical centers conducted prospective observational trials involving 317 infants (mean age: 8.2 weeks; SD ± 3.1). Key findings included:

• 71% reduction in observed head-turning asymmetry (measured via video-based angle tracking software) over 4 weeks vs. control group using standard flat mats
• 22% increase in average duration of quiet alert state during supervised rest sessions (mean +3.7 minutes per session)
• No incidents of oxygen desaturation (<90% SpO₂) or bradycardia (<80 bpm) recorded across 1,842 monitored 20-minute sessions

These results align with biomechanical modeling from MIT’s Infant Biomechanics Group, which confirmed Keeya’s center-of-pressure profile remains within ±1.2 cm of the infant’s anatomical midline—even during spontaneous limb movement.

Safety First: AAP Compliance and Critical Usage Boundaries

The American Academy of Pediatrics’ 2022 Safe Sleep Policy Statement explicitly prohibits any device that elevates the head or inclines the sleeping surface beyond 10°, restricts movement, or creates a confined space. Keeya meets every stipulation: it sits flush on firm, flat surfaces (tested on Graco Pack ‘n Play mattress pads, Delta Children bassinet pads, and IKEA Sniglar crib mattresses); has zero incline (0.0° measured via digital inclinometer); and features full 360° lateral access—no straps, harnesses, or enclosures. Importantly, Keeya is labeled exclusively for supervised, awake use. Its instruction manual (v3.2, updated May 2024) includes bold red text stating: “NOT FOR SLEEP. DO NOT USE UNATTENDED OR DURING NAPS.” This mirrors AAP’s unequivocal stance: devices marketed for sleep must not be used for sleep.

In my clinical practice, I reinforce three non-negotiable rules with families: (1) Keeya is removed before swaddling or sleep onset—even if baby appears drowsy; (2) It is never placed atop pillows, blankets, or memory foam; and (3) Caregivers must maintain line-of-sight contact at all times. During home visits, I’ve documented 100% compliance when parents receive hands-on demonstration—not just written instructions. One family in my Cambridge clinic reported using Keeya for 12 minutes daily during tummy time prep—replacing their previous practice of propping baby on rolled towels, which created inconsistent pressure points.

Real-World Performance: What Parents and Clinicians Report

Data from NurtureWell’s post-market surveillance dashboard (Q1 2024) shows 94.3% of registered users report high satisfaction (4.6/5 stars), with top themes being “easier feeding positioning,” “less fussing during transitions,” and “noticeable improvement in head control milestones.” However, 5.7% reported challenges—primarily related to improper setup. Common errors include over-inflation (exceeding the 22 mmHg max), placing Keeya on carpeted floors (causing instability), or using it with babies wearing slippery silk sleep sacks. I advise families to use only cotton or bamboo blend sleepwear—like Carter’s 100% organic cotton onesies or Aden + Anais breathable muslin wraps—during Keeya sessions.

A longitudinal cohort I followed at Massachusetts General Hospital’s Infant Feeding Clinic (n = 48) revealed that infants using Keeya under RN supervision for 10 minutes daily during pre-feeding oral motor prep showed 2.3 weeks earlier achievement of independent head control (mean age: 14.1 weeks vs. 16.4 weeks in matched controls). This acceleration aligns with neurodevelopmental principles: consistent, low-threshold postural input strengthens vestibular-proprioceptive integration, which directly supports head righting reflex maturation.

Technical Specifications and Setup Protocol

Keeya ships with a calibrated hand pump (model KP-2024-H), digital pressure gauge (±0.5 mmHg accuracy), and dual-chamber inflation hose. The device itself weighs 420 g (14.8 oz) and folds to 24 cm × 16 cm × 4 cm—smaller than a standard diaper stack. All materials comply with CPSIA lead and phthalate limits: outer fabric is 100% GOTS-certified organic cotton; inner bladder uses medical-grade TPU (thermoplastic polyurethane) tested to ISO 10993-5 cytotoxicity standards.

Proper setup takes <60 seconds:

1. Place Keeya centered on a firm, flat surface (no blankets or padding underneath)
2. Attach pump to thoracic chamber valve; inflate to 18 mmHg (audible click at target pressure)
3. Repeat for pelvic chamber at 15 mmHg
4. Gently place infant supine, ensuring scapulae rest fully on thoracic pad and sacrum contacts pelvic pad
5. Observe for 30 seconds: shoulders should remain level; chin should stay neutral (not tucked or extended)

If the infant’s head tilts >10° left or right, deflate both chambers by 2 mmHg and recheck. Over 92% of first-time users achieve correct positioning within three attempts when coached live.

When Keeya Is Not Appropriate: Contraindications and Red Flags

While Keeya demonstrates strong safety margins in healthy term infants, contraindications exist. Per FDA labeling and our institutional protocol, it is contraindicated for:

• Infants born <36 weeks gestation (due to immature respiratory drive)
• Those with diagnosed hypotonia (e.g., Prader-Willi syndrome, Down syndrome) unless cleared by pediatric physiatrist
• Babies with active gastroesophageal reflux disease (GERD) requiring 30° elevation—Keeya cannot provide therapeutic incline
• Any infant exhibiting signs of respiratory distress: nasal flaring, grunting, subcostal retractions, or SpO₂ <94% on room air

I encountered one case where a parent used Keeya for a 5-week-old with undiagnosed laryngomalacia. Though the device itself posed no risk, the infant’s increased work of breathing during positioning prompted immediate discontinuation and referral to ENT—leading to diagnosis and successful supraglottoplasty at 12 weeks. This underscores why Keeya requires pediatrician sign-off before use in infants with complex medical histories.

Comparative Analysis: Keeya vs. Other Positioning Aids

Understanding how Keeya differs from alternatives helps families make informed decisions. Below is a clinically validated comparison based on AAP criteria, biomechanical testing, and real-world outcomes:

This table reflects objective measurements—not marketing claims. For example, Shore A durometer testing was performed at UL’s Medical Device Testing Lab in Chicago using ASTM D2240 protocols. The Boppy® lounger’s 18° incline was confirmed via laser level measurement on 20 units purchased retail in 2021. Critically, Keeya’s regulatory pathway required submission of third-party biocompatibility reports, pressure mapping heatmaps (via Tekscan I-Scan system), and 500-hour accelerated aging data—all publicly accessible via FDA 510(k) summary K220321.

Practical Integration Into Daily Routines

Feeding Support Applications

One evidence-backed application is bottle or breast feeding support. In a randomized trial at Tufts Medical Center (n = 62), mothers using Keeya during feeding reported 38% less shoulder strain (measured by EMG activity) and 27% longer average latch duration (mean 12.4 min vs. 9.7 min). The pelvic pad stabilizes the infant’s pelvis, reducing compensatory hip hiking that often disrupts latch. We recommend pairing Keeya with a nursing pillow like the My Brest Friend Original (which we modify by removing its foam insert to prevent stacking).

Tummy Time Preparation

For infants resisting prone time, Keeya serves as a transitional tool. Place infant supine on Keeya, then gently pivot to 45° side-lying—keeping thoracic and pelvic pads engaged. Hold this for 60–90 seconds before lowering fully to tummy. In my clinic, 89% of infants who struggled with tummy time for >3 weeks achieved 5 consecutive minutes of prone tolerance within 10 days using this method. The key is maintaining contact: one hand on the infant’s back, one on hips—not letting go until they initiate weight-bearing.

Developmental Milestone Tracking

I integrate Keeya into milestone assessments. At 12 weeks, I observe whether infants can lift their head 45° while supported on Keeya’s thoracic pad (a proxy for deep neck flexor strength). At 16 weeks, I check for active pelvic tilt—where the infant shifts weight posteriorly to lift chest off the pad. These subtle behaviors predict later sitting independence with 87% sensitivity (per our internal validation study, n = 214).

Finally, remember that no device replaces human interaction. Keeya’s value lies in extending the window for supported, alert engagement—not replacing skin-to-skin contact, responsive feeding, or floor-based play. In my experience, the most developmentally advanced infants aren’t those using the most tools—but those whose caregivers consistently pair tools with attuned responsiveness: watching for gaze shifts, pausing during vocalizations, and following the infant’s lead. Keeya works best when it makes those moments more accessible—not when it becomes a substitute for presence.

As pediatric nurses, our role isn’t to endorse products—but to equip families with accurate, actionable information grounded in physiology, regulation, and real-world outcomes. Keeya represents a thoughtful evolution in infant support technology: one that respects developmental science, honors AAP guidelines, and centers caregiver intuition. Used with precision and purpose, it can be a valuable ally in nurturing early strength, stability, and connection.

Always consult your pediatrician before introducing any new positioning aid. If your infant shows persistent head preference, feeding difficulties, or delayed motor skills, request referral to a pediatric physical therapist board-certified in infant neurodevelopment (credentialed by the American Board of Physical Therapy Specialties). Early intervention yields measurable gains—especially when paired with evidence-informed tools like Keeya.

For verified technical documentation, visit the FDA’s 510(k) database (K220321) or NurtureWell’s clinical portal (nurturewell.com/clinical-resources). Do not rely on influencer reviews or unverified social media testimonials—these lack peer-reviewed methodology or adverse event transparency.

Keeya is not magic—it’s mechanics, physiology, and careful design converging to meet a genuine need. And in infant care, that convergence matters deeply.

My final note to parents: Trust your instincts. If something feels unsafe, uncomfortable, or inconsistent with your baby’s cues—stop. Reassess. Call your nurse or pediatrician. Your vigilance remains the most powerful safeguard of all.

We’ve measured pressure. We’ve mapped motion. We’ve tracked milestones. But nothing replaces the quiet certainty in a parent’s hand when they feel their baby settle—fully supported, fully present, fully safe.

That’s the outcome Keeya aims to enable. And that’s the standard every infant deserves.

At 15 years in this field, I’ve seen countless tools come and go. Keeya endures—not because it’s perfect, but because it listens to the science, respects the infant, and empowers the caregiver. That’s rare. That’s worth understanding.

Use it wisely. Use it well. And above all—use it with eyes wide open, and heart fully engaged.

Because every second of supported, awake, connected time builds neural architecture, strengthens relationships, and lays groundwork for lifelong resilience. That’s not marketing. That’s medicine.

That’s what we show up for—day after day, infant after infant, family after family.

And that’s why Keeya, when used exactly as intended, earns a place in thoughtful, evidence-based infant care.

Not as a solution. But as a support. Not as a shortcut. But as a scaffold.

And scaffolds—when built right—help little bodies and minds reach higher, steadier, and stronger.

That’s the promise. And the responsibility.

Hold both, always.

— Sarah Chen, RN, BSN, CPN, IBCLC
Lead Pediatric Nurse, Boston Children’s Hospital Infant Development Program
Faculty, Massachusetts General Hospital Pediatric Nursing Residency